Navigation Links
Bard Composix Mesh

ProductsBard Composix Mesh
Company Davol, Inc.
Item Bard Composix Mesh
Features 
  • Designed to meet the specific demands of ventral hernia repair
  • Made of Bard mesh on one side, bonded to ePTFE on the other
  • Can be used in a "tension-free" surgical technique similar to all of the products in the Bard mesh line
  • Description When it comes to ventral hernia repair, there's a lot that needs to be said. While a hernia is often best treated with a prosthesis, for some ventral hernia applications there's concern about the risk of bowel adhesions to currently available products. Fortunately, we have Bard Composix mesh, an innovative product designed to meet the specific demands of ventral hernia repair. Bard Composix mesh is made of Bard mesh on one side, bonded to ePTFE on the other; two clinically proven materials with truly complementary benefits. While Bard mesh provides tissue ingrowth and keeps the prosthesis in place, ePTFE acts as a barrier, preventing the Bard mesh from coming into contact with any adjacent organs - thereby minimizing the risk of adhesion to the prosthesis. Moreover, Bard Composix mesh can be used in a "tension-free" surgical technique similar to all of the products in the Bard mesh line. Bard Composix mesh is another product from Bard, an innovator in hernia repair for nearly forty years.
    Info Davol, Inc.
    Customer Service: (800) 556-6756
    Web site: http://www.davol.com/

    Related medicine products :

    1. Bard Composix Kugel Hernia Patch
    2. Bard® Composix® E/X Mesh
    The most advanced retinal cameras for fluorescein, color and ICG angiography with full digital imaging capability....
    All welded construction for strength and durability. Choice of stainless steel or chrome plated models. One forward leg with caster for increased mobility....
    All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
    Ideal for surgical procedures, these portable stands fit into tight areas for easy instrument access. Easy placement over patient....
    Medicine Products:
    (Date:3/23/2017)... ... 2017 , ... The StayWell Company announced today that it ... StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, and ... programs for the delivery and improvement of disease management and that meet or ...
    (Date:3/23/2017)... , ... March 23, 2017 , ... ... training program owned and organized by HMP Communications Holdings, LLC, today announced that ... physicians within its nationwide network of wound centers interested in becoming Certified Wound ...
    (Date:3/23/2017)... Collins, CO (PRWEB) , ... March 23, 2017 ... ... firm serving the families and businesses of the greater Fort Collins area, has ... campaign in their ongoing community involvement program. Donations to this worthy cause may ...
    (Date:3/23/2017)... York City (PRWEB) , ... March 23, 2017 , ... ... last fall, FaceCradle , the most-funded travel pillow in crowdfunding history, ... speed delivery of its wildly popular travel innovation to Americans. , “We’re excited to ...
    (Date:3/23/2017)... ... ... ?This conference will prominently feature 150+ Hospital and Health System Executive Speakers including: , ... 43rd President of the United States of America: George W. Bush , ... of the Ring: Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw ...
    Breaking Medicine News(10 mins):
    (Date:3/23/2017)... 2017 Research and Markets has announced the ... to their offering. ... The global capillary electrophoresis market to grow at a CAGR ... Global Capillary Electrophoresis Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
    (Date:3/23/2017)... 2017 Newborns are highly vulnerable to ... because their young immune systems typically mount weak ... report achieving strong vaccine responses in newborn animals, ... human trials — by adding compounds known as ... simultaneous papers, they also describe improved adjuvant formulations ...
    (Date:3/23/2017)... 23, 2017 Prima BioMed has ... trial of IMP321 in combination with Keytruda, with one ... cohort experiencing a complete response. Recruitment in the second ... to be fully recruited by Q317. Preliminary efficacy data ... cancer study are expected mid-year (recruitment in the 226-patient ...
    Breaking Medicine Technology: